Henry Newman - Profile and Investment Details

Investor Profile

Henry Newman is a Venture Capital, Private Equity Firm, Micro VC based in Marblehead, Massachusetts, United States with a diverse investment portfolio that includes companies such as Evergreen Solar, Protonex Technology Corporation, Sequencia, CellzDirect, Arxan Technologies, HTG Molecular Diagnostics, Splash Pharmaceuticals, E Ink, Astoria Software, PhotoThera, Unveil Technologies, Carefx, MetaCarta, Q1 Labs, CodeRyteI2 Technologies, Pharsight, Regenesis Biomedical, Supplyworks, AmpliMed Corporation, Connected Corporation, Angstrom Pharmaceuticals, Lumidigm, Archivas, Okena, Lumigent Technologies, Abuzz Technologies, . Over time, Henry Newman has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Henry Newman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Cybersecurity, Wellness, Women Founded, Android, Life Science, Identity Management, Analytics, Internet of Things (IoT), Mobile, Software, Biotechnology, Genomics, Natural Language Processing, Reviews and Recommendations, Consulting, Health Diagnostics, Medical, Real Estate, Therapeutics, Media and Entertainment, Point of Sale (POS), Pharmaceuticals, Biometrics may find it worthwhile to explore potential connections with Henry Newman, as their portfolio suggests a familiarity and interest in this area.

Understanding Henry Newman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.